Chronically Elevating Circulating Ketones Can Reduce Cardiac Inflammation and Blunt the Development of Heart Failure
出版年份 2020 全文链接
标题
Chronically Elevating Circulating Ketones Can Reduce Cardiac Inflammation and Blunt the Development of Heart Failure
作者
关键词
-
出版物
Circulation-Heart Failure
Volume 13, Issue 6, Pages -
出版商
Ovid Technologies (Wolters Kluwer Health)
发表日期
2020-06-04
DOI
10.1161/circheartfailure.119.006573
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Empagliflozin Blunts Worsening Cardiac Dysfunction Associated With Reduced NLRP3 (Nucleotide-Binding Domain-Like Receptor Protein 3) Inflammasome Activation in Heart Failure
- (2020) Nikole J. Byrne et al. Circulation-Heart Failure
- Inflammation and NLRP3 Inflammasome Activation Initiated in Response to Pressure Overload by Ca 2+ /Calmodulin-Dependent Protein Kinase II δ Signaling in Cardiomyocytes Are Essential for Adverse Cardiac Remodeling
- (2019) Takeshi Suetomi et al. CIRCULATION
- The activation of retinal HCA2 receptors by systemic beta-hydroxybutyrate inhibits diabetic retinal damage through reduction of endoplasmic reticulum stress and the NLRP3 inflammasome
- (2019) Maria Consiglia Trotta et al. PLoS One
- Cardiovascular Effects of Treatment with the Ketone Body 3-Hydroxybutyrate in Chronic Heart Failure Patients
- (2019) Roni Nielsen et al. CIRCULATION
- MCC950 directly targets the NLRP3 ATP-hydrolysis motif for inflammasome inhibition
- (2019) Rebecca C. Coll et al. Nature Chemical Biology
- α1-AR overactivation induces cardiac inflammation through NLRP3 inflammasome activation
- (2019) Jun-zhou Xin et al. ACTA PHARMACOLOGICA SINICA
- The macrophage phenotype and inflammasome component NLRP3 contributes to nephrocalcinosis-related chronic kidney disease independent from IL-1–mediated tissue injury
- (2018) Hans-Joachim Anders et al. KIDNEY INTERNATIONAL
- Plasma levels of heart failure biomarkers are primarily a reflection of extracardiac production
- (2018) Weijie Du et al. Theranostics
- Cardioprotective Effects of CYP-Derived Epoxy Metabolites of Docosahexaenoic Acid Involve Limiting NLRP3 Inflammasome Activation
- (2018) Ahmed M. Darwesh et al. CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY
- Salt-Responsive Metabolite, β-Hydroxybutyrate, Attenuates Hypertension
- (2018) Saroj Chakraborty et al. Cell Reports
- Beta-hydroxybutyrate, an endogenic NLRP3 inflammasome inhibitor, attenuates stress-induced behavioral and inflammatory responses
- (2017) Takehiko Yamanashi et al. Scientific Reports
- β-Hydroxybutyrate Deactivates Neutrophil NLRP3 Inflammasome to Relieve Gout Flares
- (2017) Emily L. Goldberg et al. Cell Reports
- Ketone Body Infusion With 3‐Hydroxybutyrate Reduces Myocardial Glucose Uptake and Increases Blood Flow in Humans: A Positron Emission Tomography Study
- (2017) Lars C. Gormsen et al. Journal of the American Heart Association
- Nutritional Ketosis Alters Fuel Preference and Thereby Endurance Performance in Athletes
- (2016) Pete J. Cox et al. Cell Metabolism
- Evidence for Intramyocardial Disruption of Lipid Metabolism and Increased Myocardial Ketone Utilization in Advanced Human Heart Failure
- (2016) Kenneth C. Bedi et al. CIRCULATION
- The Failing Heart Relies on Ketone Bodies as a Fuel
- (2016) Gregory Aubert et al. CIRCULATION
- Novel ketone diet enhances physical and cognitive performance
- (2016) Andrew J. Murray et al. FASEB JOURNAL
- β-Hydroxybutyrate suppresses inflammasome formation by ameliorating endoplasmic reticulum stress via AMPK activation
- (2016) Ha Ram Bae et al. Oncotarget
- The Importance of NLRP3 Inflammasome in Heart Failure
- (2015) Brittany Butts et al. JOURNAL OF CARDIAC FAILURE
- The ketone metabolite β-hydroxybutyrate blocks NLRP3 inflammasome–mediated inflammatory disease
- (2015) Yun-Hee Youm et al. NATURE MEDICINE
- Metabolomic Fingerprint of Heart Failure with Preserved Ejection Fraction
- (2015) Beshay N. Zordoky et al. PLoS One
- TXNIP mediates NLRP3 inflammasome activation in cardiac microvascular endothelial cells as a novel mechanism in myocardial ischemia/reperfusion injury
- (2014) Yi Liu et al. BASIC RESEARCH IN CARDIOLOGY
- �-Hydroxybutyrate Activates the NF-κB Signaling Pathway to Promote the Expression of Pro-Inflammatory Factors in Calf Hepatocytes
- (2014) Xiaoxia Shi et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Nlrp3 plays no role in acute cardiac infarction due to low cardiac expression
- (2014) Willeke M.C. Jong et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- BHBA Suppresses LPS-Induced Inflammation in BV-2 Cells by Inhibiting NF-κB Activation
- (2014) Shou-Peng Fu et al. MEDIATORS OF INFLAMMATION
- 1H-NMR-Based Metabolic Analysis of Human Serum Reveals Novel Markers of Myocardial Energy Expenditure in Heart Failure Patients
- (2014) Zhiyong Du et al. PLoS One
- Ketone bodies as signaling metabolites
- (2013) John C. Newman et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Successful adaptation to ketosis by mice with tissue-specific deficiency of ketone body oxidation
- (2012) David G. Cotter et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Urinary ketone is associated with the heart failure severity
- (2012) Ji Hyung Chung et al. CLINICAL BIOCHEMISTRY
- Fibrosis and heart failure
- (2012) Ana Maria Segura et al. HEART FAILURE REVIEWS
- Suppression of Oxidative Stress by -Hydroxybutyrate, an Endogenous Histone Deacetylase Inhibitor
- (2012) T. Shimazu et al. SCIENCE
- Obligate Role for Ketone Body Oxidation in Neonatal Metabolic Homeostasis
- (2011) David G. Cotter et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Molecular mechanisms that control interstitial fibrosis in the pressure-overloaded heart
- (2010) E. E. Creemers et al. CARDIOVASCULAR RESEARCH
- Inflammatory Biomarkers in Heart Failure Revisited: Much More than Innocent Bystanders
- (2009) Stephan von Haehling et al. Heart Failure Clinics
- The neuroprotective properties of calorie restriction, the ketogenic diet, and ketone bodies
- (2008) Marwan Maalouf et al. BRAIN RESEARCH REVIEWS
- Tissue inhibitor of metalloproteinases levels in patients with chronic heart failure: An independent predictor of mortality
- (2008) S. Frantz et al. EUROPEAN JOURNAL OF HEART FAILURE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started